Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:596-605
doi: 10.1161/01.RES.0000207406.94146.c2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poornima, I. G.
Right arrow Articles by Shannon, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poornima, I. G.
Right arrow Articles by Shannon, R. P.
Related Collections
Right arrow Congestive
Right arrow Myocardial cardiomyopathy disease
Right arrow Type 1 diabetes
Right arrow Type 2 diabetes
(Circulation Research. 2006;98:596.)
© 2006 American Heart Association, Inc.


Reviews

Diabetic Cardiomyopathy

The Search for a Unifying Hypothesis

Indu G. Poornima, Pratik Parikh, Richard P. Shannon

From the Department of Medicine, Allegheny General Hospital, Pittsburgh; and the Drexel University College of Medicine, Philadelphia, Pa.

Correspondence to Richard P. Shannon, MD, Department of Medicine, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212. E-mail rshannon{at}wpahs.org

This Review is part of a thematic series on Adipocyte Signaling in the Cardiovascular System, which includes the following articles:

Adipose Tissue, Inflammation, and Cardiovascular Disease

Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin Resistant Adipose Tissue

Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis

Adipocyte Signaling and the Vasculature

PPAR{gamma} Activation and Effects on the Vasculature
Phillip Scherer Guest Editor

Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart disease, less is known as to whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Left ventricular systolic and diastolic dysfunction, left ventricular hypertrophy, and alterations in the coronary microcirculation have all been observed, although not consistently, in diabetic cardiomyopathy and are not fully explained by the cellular effects of hyperglycemia alone. The recent recognition that diabetes involves more than abnormal glucose homeostasis provides important new opportunities to examine and understand the impact of complex metabolic disturbances on cardiac structure and function.


Key Words: insulin resistance • diabetic cardiomyopathy • diastolic function • cardiac hypertrophy




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde
Insulin signalling in the heart
Cardiovasc Res, July 15, 2008; 79(2): 238 - 248.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. R. MacDonald, M. C. Petrie, F. Varyani, J. Ostergren, E. L. Michelson, J. B. Young, S. D. Solomon, C. B. Granger, K. Swedberg, S. Yusuf, et al.
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
Eur. Heart J., June 1, 2008; 29(11): 1377 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Kindermann and M. Bohm
Sweet hearts die earlier--lessons from CHARM
Eur. Heart J., June 1, 2008; 29(11): 1342 - 1343.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Ueno, J. Suzuki, Y. Zenimaru, S. Takahashi, T. Koizumi, S. Noriki, O. Yamaguchi, K. Otsu, W.-J. Shen, F. B. Kraemer, et al.
Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1109 - E1118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Venkatachalam, S. Mummidi, D. M. Cortez, S. D. Prabhu, A. J. Valente, and B. Chandrasekar
Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2078 - H2087.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Van Linthout, F. Spillmann, A. Riad, C. Trimpert, J. Lievens, M. Meloni, F. Escher, E. Filenberg, O. Demir, J. Li, et al.
Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic Cardiomyopathy
Circulation, March 25, 2008; 117(12): 1563 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D.-F. Yeih, L.-Y. Lin, H.-I Yeh, Y.-J. Lai, F.-T. Chiang, C.-D. Tseng, S.-H. Chu, and Y.-Z. Tseng
Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H867 - H874.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al.
Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension
Circulation, January 1, 2008; 117(1): 43 - 51.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases
PNAS, December 18, 2007; 104(51): 20517 - 20522.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Lu, Y.-P. Jiang, X.-H. Xu, L. M. Ballou, I. S. Cohen, and R. Z. Lin
Decreased L-Type Ca2+ Current in Cardiac Myocytes of Type 1 Diabetic Akita Mice Due to Reduced Phosphatidylinositol 3-Kinase Signaling
Diabetes, November 1, 2007; 56(11): 2780 - 2789.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.A. Connelly, D.J. Kelly, Y. Zhang, D.L. Prior, J. Martin, A.J. Cox, K. Thai, M.P. Feneley, J. Tsoporis, K.E. White, et al.
Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat
Cardiovasc Res, November 1, 2007; 76(2): 280 - 291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. L. Ruberg
Myocardial Lipid Accumulation in the Diabetic Heart
Circulation, September 4, 2007; 116(10): 1110 - 1112.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Belmadani, J. Bernal, C.-C. Wei, M. A. Pallero, L. Dell'Italia, J. E. Murphy-Ullrich, and K. H. Berecek
A Thrombospondin-1 Antagonist of Transforming Growth Factor-{beta} Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II
Am. J. Pathol., September 1, 2007; 171(3): 777 - 789.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kobayashi, K. Mao, H. Zheng, X. Wang, C. Patterson, T. D. O'Connell, and Q. Liang
Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury
J. Biol. Chem., July 27, 2007; 282(30): 21945 - 21952.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation, July 24, 2007; 116(4): 434 - 448.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. M. Davidson and M. R. Duchen
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Circ. Res., April 27, 2007; 100(8): 1128 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. G. Laustsen, S. J. Russell, L. Cui, A. Entingh-Pearsall, M. Holzenberger, R. Liao, and C. R. Kahn
Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function
Mol. Cell. Biol., March 1, 2007; 27(5): 1649 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Qi and B. Rodrigues
Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Loganathan, M. Bilgen, B. Al-Hafez, S. V. Zhero, M. D. Alenezy, and I. V. Smirnova
Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses
J Appl Physiol, February 1, 2007; 102(2): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Fulop, R. B. Marchase, and J. C. Chatham
Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system
Cardiovasc Res, January 15, 2007; 73(2): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, C. Medana, M. G. Catalano, I. Vercellinatto, O. Danni, and G. Boccuzzi
Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes
Endocrinology, December 1, 2006; 147(12): 5967 - 5974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506.
[Abstract] [Full Text] [PDF]